Leptomeningeal disease in oligodendroglial tumors: a population-based study

Por Roldán, Gloria, Chan, Jennifer, Eliasziw, Misha, Cairncross, J. Gregory, Forsyth, Peter A.
Publicado em 2011

Managing leptomeningeal melanoma metastases in the era of immune and targeted therapy

Por Smalley, Keiran S.M., Fedorenko, Inna V., Kenchappa, Rajappa, Sahebjam, Solmaz, Forsyth, Peter A.
Publicado no Int J Cancer (2016)

BIRC3 is a novel driver of therapeutic resistance in Glioblastoma

Por Wang, Dapeng, Berglund, Anders, Kenchappa, Rajappa S., Forsyth, Peter A., Mulé, James J., Etame, Arnold B.
Publicado no Sci Rep (2016)

Cellular factors promoting resistance to effective treatment of glioma with oncolytic Myxoma virus

Por Zemp, Franz J., McKenzie, Brienne A., Lun, Xueqing, Reilly, Karlyne M., McFadden, Grant, Yong, V. Wee, Forsyth, Peter A.
Publicado no Cancer Res (2014)

Myxoma Virus Infection Promotes NK Lysis of Malignant Gliomas In Vitro and In Vivo

Por Ogbomo, Henry, Zemp, Franz J., Lun, Xueqing, Zhang, Jiqing, Stack, Danuta, Rahman, Masmudur M., Mcfadden, Grant, Mody, Christopher H., Forsyth, Peter A.
Publicado em 2013

Resistance to Oncolytic Myxoma Virus Therapy in Nf1(−/−)/Trp53(−/−) Syngeneic Mouse Glioma Models Is Independent of Anti-Viral Type-I Interferon

Por Zemp, Franz J., McKenzie, Brienne A., Lun, Xueqing, Maxwell, Lori, Reilly, Karlyne M., McFadden, Grant, Yong, V. Wee, Forsyth, Peter A.
Publicado em 2013

In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells

Por McKenzie, Brienne A., Zemp, Franz J., Pisklakova, Alexandra, Narendran, Aru, McFadden, Grant, Lun, Xueqing, Kenchappa, Rajappa S., Kurz, Ebba U., Forsyth, Peter A.
Publicado no Neuro Oncol (2015)

Gamma-Secretase Represents a Therapeutic Target for the Treatment of Invasive Glioma Mediated by the p75 Neurotrophin Receptor

Por Wang, LiMei, Rahn, Jennifer J, Lun, XueQing, Sun, Beichen, Kelly, John J. P, Weiss, Samuel, Robbins, Stephen M, Forsyth, Peter A, Senger, Donna L
Publicado em 2008

Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells

Por Lawn, Samuel, Krishna, Niveditha, Pisklakova, Alexandra, Qu, Xiaotao, Fenstermacher, David A., Fournier, Michelle, Vrionis, Frank D., Tran, Nam, Chan, Jennifer A., Kenchappa, Rajappa S., Forsyth, Peter A.
Publicado no J Biol Chem (2015)

An exploratory analysis of common genetic variants in the vitamin D pathway including genome-wide associated variants in relation to glioma risk and outcome

Por Anic, Gabriella M., Thompson, Reid C., Nabors, L. Burton, Olson, Jeffrey J., Browning, James E., Madden, Melissa H., Murtagh, F. Reed, Forsyth, Peter A., Egan, Kathleen M.
Publicado em 2012

Oncolytic Efficacy of Recombinant Vesicular Stomatitis Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors

Por Wu, Yushui, Lun, Xueqing, Zhou, Hongyuan, Wang, Limei, Sun, Beichen, Bell, John C., Barrett, John W., McFadden, Grant, Biegel, Jaclyn A., Senger, Donna L., Forsyth, Peter A.
Publicado em 2008

Myxoma Virus Is a Novel Oncolytic Virus with Significant Antitumor Activity against Experimental Human Gliomas

Por Lun, Xueqing, Yang, Wenqing, Alain, Tommy, Shi, Zhong-Qiao, Muzik, Huong, Barrett, John W., McFadden, Grant, Bell, John, Hamilton, Mark G., Senger, Donna L., Forsyth, Peter A.
Publicado no Cancer Res (2005)

Targeting Human Medulloblastoma: Oncolytic Virotherapy with Myxoma Virus Is Enhanced by Rapamycin

Por Lun, Xue Qing, Zhou, Hongyuan, Alain, Tommy, Sun, Beichen, Wang, Limei, Barrett, John W., Stanford, Marianne M., McFadden, Grant, Bell, John, Senger, Donna L., Forsyth, Peter A.
Publicado no Cancer Res (2007)

Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties

Por Rodrigues, Jennifer C., Gonzalez, Guido C., Zhang, Lei, Ibrahim, George, Kelly, John J., Gustafson, Michael P., Lin, Yi, Dietz, Allan B., Forsyth, Peter A., Yong, V. Wee, Parney, Ian F.
Publicado em 2010

M011L-deficient oncolytic myxoma virus induces apoptosis in brain tumor-initiating cells and enhances survival in a novel immunocompetent mouse model of glioblastoma

Por Pisklakova, Alexandra, McKenzie, Brienne, Zemp, Franz, Lun, Xueqing, Kenchappa, Rajappa S., Etame, Arnold B., Rahman, Masmudur M., Reilly, Karlyne, Pilon-Thomas, Shari, McFadden, Grant, Kurz, Ebba, Forsyth, Peter A.
Publicado no Neuro Oncol (2016)

The p75 Neurotrophin Receptor Is a Central Regulator of Glioma Invasion

Por Johnston, Angela L. M, Lun, Xueqing, Rahn, Jennifer J, Liacini, Abdelhamid, Wang, Limei, Hamilton, Mark G, Parney, Ian F, Hempstead, Barbara L, Robbins, Stephen M, Forsyth, Peter A, Senger, Donna L
Publicado em 2007

Toenail iron, genetic determinants of iron status and the risk of glioma

Por Anic, Gabriella M., Madden, Melissa H., Thompson, Reid C., Nabors, L. Burton, Olson, Jeffrey J., LaRocca, Renato V., Browning, James E., Brockman, John D., Forsyth, Peter A., Egan, Kathleen M.
Publicado em 2013

Reproductive Factors and Risk of Primary Brain Tumors in Women

Por Anic, Gabriella M., Madden, Melissa H., Nabors, L. Burton, Olson, Jeffrey J., LaRocca, Renato V., Thompson, Zachary J., Pamnani, Shitaldas J., Forsyth, Peter A., Thompson, Reid C., Egan, Kathleen M.
Publicado em 2014

Analgesic Use and the Risk of Primary Adult Brain Tumor

Por Egan, Kathleen M., Nabors, L. Burton, Thompson, Zachary J., Rozmeski, Carrie M., Anic, Gabriella A., Olson, Jeffrey J., LaRocca, Renato V., Chowdhary, Sajeel A., Forsyth, Peter A., Thompson, Reid C.
Publicado no Eur J Epidemiol (2016)

p75 Neurotrophin Receptor Cleavage by α- and γ-Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells

Por Forsyth, Peter A., Krishna, Niveditha, Lawn, Samuel, Valadez, J. Gerardo, Qu, Xiaotao, Fenstermacher, David A., Fournier, Michelle, Potthast, Lisa, Chinnaiyan, Prakash, Gibney, Geoffrey T., Zeinieh, Michele, Barker, Philip A., Carter, Bruce D., Cooper, Michael K., Kenchappa, Rajappa S.
Publicado em 2014